Platelet Inhibition Agents: Current and Future P2Y12 Receptor Antagonists

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|13|5|566-577

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.13, Iss.5, 2015-01, pp. : 566-577

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Future Prospects in Anti-Platelet Therapy: A Review of Potential P2Y12 and Thrombin Receptor Antagonists

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. : 194-200

Bentham Science Publishers

Access to resources Recommend Favorite

Succinate reverses in-vitro platelet inhibition by acetylsalicylic acid and P2Y receptor antagonists

By Spath Brigitte   Hansen Arne   Bokemeyer Carsten   Langer Florian  

Platelets, Vol. 23, Iss. 1, 2012-02 ,pp. : 60-68

Informa Healthcare

Access to resources Recommend Favorite

P2Y12 receptor in platelet activation

By Kim Soochong   Kunapuli Satya P.  

Platelets, Vol. 22, Iss. 1, 2011-02 ,pp. : 54-58

Informa Healthcare

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses

By Judge Heather M.   Buckland Robert J.   Holgate Carol E.   Storey Robert F.  

Platelets, Vol. 16, Iss. 7, 2005-11 ,pp. : 398-407

Informa Healthcare

Access to resources Recommend Favorite

Effects of P2Y1 and P2Y12 receptor antagonists on platelet aggregation induced by different agonists in human whole blood

By Storey Robert F.   Newby Linda J.   Heptinstall Stan  

Platelets, Vol. 12, Iss. 7, 2001-11 ,pp. : 443-447

Informa Healthcare

Access to resources Recommend Favorite